These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 175889)

  • 1. [Use of Cortrosyn Depot in dermatology].
    Aussems J
    Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthetic ACTH in theumatic diseases: (author's transl)].
    Hieber F
    MMW Munch Med Wochenschr; 1975 Nov; 117(46):1849-52. PubMed ID: 172785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ACTH therapy of dermatoses].
    Schuppli R
    Hautarzt; 1977 Jan; 28(1):1-4. PubMed ID: 190189
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of depot synacthen therapy in dermatoses. A report of over 6-years' experiences].
    Harnack K; Flegel P
    Dermatol Monatsschr; 1984; 170(4):237-43. PubMed ID: 6329833
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term Cortrosyn-depot therapy of steroid-dependent patients suffering from bronchial asthma].
    Rott Z; Fajt E; Tóth S; Hammer I; Nagy G
    Orv Hetil; 1983 Jul; 124(31):1883-6. PubMed ID: 6314223
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen].
    Roldaan AC; de Jong C
    Ned Tijdschr Geneeskd; 1981 Feb; 125(8):321-3. PubMed ID: 6261167
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synacthene-Retard in mental confusion of aged patients].
    Porte M; Juttner G; Michelangeli J; Krebs BP; Lavagna J; Capdeville C; Darcourt G
    Ann Med Psychol (Paris); 1979; 137(5):481-90. PubMed ID: 228577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tetracosactide in the treatment of rheumatoid arthritis and gout].
    Usobiaga JL
    Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
    Kropp R
    Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stimulation of the adrenal cortex in long-term steroid therapy. Increase of free cortisol in the urine following depot ACTH administration].
    Nolte D; Gallenberger S; Borgolte H; Vecsei P; Haack D
    Fortschr Med; 1986 Jun; 104(22):444-7. PubMed ID: 3017824
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)].
    Bordier C; Flechet ML; Thomine E; Lauret P
    Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synacthen depot in the treatment of psoriatic arthritis].
    Chichenina IV; Rakhmatov AB
    Vestn Dermatol Venerol; 1988; (9):64-6. PubMed ID: 3213224
    [No Abstract]   [Full Text] [Related]  

  • 13. Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema.
    Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():135-8. PubMed ID: 178340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Discussion of a case of dyschromia].
    Nicolay M; Piot V
    Arch Belg Dermatol; 1974; 30(2):99-101. PubMed ID: 4377809
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of the adrenal cortex reserve using depot beta 1-24-corticotrophin. II---in thyroid diseases.
    Galvão-Teles A
    Acta Med Port; 1979; 1(3):315-24. PubMed ID: 233190
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of hormonal treatment of threatened abortion].
    Skolicki Z
    Folia Med Cracov; 1980; 22(1):137-49. PubMed ID: 6254862
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience using sinakten-retard in the treatment of muscular sclerosis].
    Neretin VIa; Kir'iakov VA; Pegova LN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):514-8. PubMed ID: 207061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.
    Glass D; Roffe L; Maini RN; Wraith DG; Nuki G
    Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synacthen depot-induced liver damage in the therapy of secondary generalized epilepsies in childhood].
    John K; Gaida P; Kauf E
    Padiatr Grenzgeb; 1985; 24(5):391-9. PubMed ID: 2999679
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synacthen retard].
    Ménégol B; Brard M
    Soins; 1985 Apr; (451):I-II. PubMed ID: 3008345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.